Application of ceramide synthase 6 gene as target spot in pest control

Targeted editing of CerS6 genes of Lepidoptera insects through CRISPR/Cas technology, solving the problems of drug resistance and environmental pollution in traditional control methods, achieving effective control of pests such as twilliasis, and reducing their reproductive ability and growth and development .

CN118910102AActive Publication Date: 2024-11-08SOUTH CHINA NORMAL UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410875987.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-02
Publication Date
2024-11-08
Estimated Expiration
2044-07-02

AI Technical Summary

Technical Problem

The prior art is difficult to effectively control Lepidopteran insects, especially pests such as the Twill, and traditional methods may lead to drug resistance and environmental pollution.

Method used

CRISPR/Cas technology targets knockout or knockdown of ceramide synthase 6 gene (CerS6), and uses specific sgRNA to bind to Cas proteins to gene edit the Lepidopteran insects, affecting their growth, development and reproductive ability.

Benefits of technology

It successfully reduces the egg laying and hatching rate of pests, significantly affects their growth and development, and does not develop drug resistance, is harmless to humans, animals and the environment, and achieves long-lasting pest control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004923037290000071
    Figure BDA0004923037290000071
  • Figure BDA0004923037290000072
    Figure BDA0004923037290000072
  • Figure BDA0004923037290000081
    Figure BDA0004923037290000081
Patent Text Reader

Abstract

The invention belongs to the technical field of pest control, discloses application of a ceramide synthase 6 gene as a target spot in pest control, and particularly discloses application of a CerS6 gene as a target spot in lepidoptera insect control. The invention discloses the application of the ceramide synthase CerS6 gene as a target spot in prevention and control of lepidoptera insects for the first time, the ceramide synthase CerS6 of prodenia litura is knocked out through target gene screening in combination with a CRISPR / Cas9 technology, the importance of the ceramide synthase CerS6 to growth and development and reproductive capacity of pests is proved, and a great contribution is made to biological pest prevention and control.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of pest control, and specifically relates to the application of ceramide synthase 6 gene as a target in pest control. Background Art

[0002] Ceramide is an important lipid in organisms and is closely related to physiological processes such as obesity, inflammation, and neurodegeneration. Ceramide synthase (CerS) plays a key role in the production of ceramide. In mammals, there are 6 homologous genes encoding ceramide synthase, while there is only one in fruit flies. Although knocking out ceramide synthase in fruit flies can lead to reduced body size, the function of this enzyme in growth and development in lepidopteran insects is still unclear. Therefore, it is of great significance to deeply study the biological function of CerS.

[0003] Spodoptera litura, Noctuidae, Spodoptera genus, scientific name Spodoptera litura. Spodoptera litura is a type of omnivorous agricultural pest. Its larvae feed on leaves of nearly 300 plants such as sweet potatoes, soybeans, beets, and cruciferous and solanaceous vegetables. It is an excellent experimental material for studying the functions of Lepidoptera pests. Summary of the invention

[0004] The purpose of the first aspect of the present invention is to provide the use of CerS6 gene as a target in controlling Lepidoptera insects.

[0005] The second aspect of the present invention aims to provide a sgRNA.

[0006] The purpose of the third aspect of the present invention is to provide biological materials related to the sgRNA of the second aspect of the present invention.

[0007] The purpose of the fourth aspect of the present invention is to provide the use of the sgRNA of the second aspect of the present invention or the biological material of the third aspect of the present invention in controlling Lepidoptera insects.

[0008] The fifth aspect of the present invention aims to provide a product.

[0009] The sixth aspect of the present invention aims to provide a method for controlling pests.

[0010] The purpose of the seventh aspect of the present invention is to provide a CRISPR / Cas system.

[0011] In order to achieve the above object, the technical solution adopted by the present invention is:

[0012] The first aspect of the present invention provides the use of CerS6 gene as a target in a1) and / or a2);

[0013] a1) Control of Lepidoptera insects;

[0014] a2) Screening and / or preparing products for controlling lepidopteran insects.

[0015] In some embodiments of the present invention, the nucleotide sequence of the CerS6 gene is shown in SEQ ID NO:1.

[0016] In some embodiments of the present invention, the purpose of controlling lepidopteran insects is achieved by targeted knockout / knockdown of the CerS6 gene.

[0017] In some embodiments of the present invention, CRISPR / Cas technology is used to target and knock out / knock down the CerS6 gene. The nucleotide sequence of the sgRNA involved is GAACGCTGGTGGCTTCCTAACGG, wherein A, C, G and T are nucleotide components including modified nucleotide components.

[0018] In some embodiments of the present invention, the lepidopteran insects include one or more of Spodoptera litura, Spodoptera minor, Manduca sexta, Monarch butterfly, Cotton bollworm, Bombyx mori, Plutella xylostella, Spodoptera exigua and Spodoptera frugiperda.

[0019] In a second aspect of the present invention, a sgRNA is provided, wherein the sgRNA targets the CerS6 gene and can knock out / knock down the CerS6 gene together with the Cas protein.

[0020] In some embodiments of the invention, the nucleotide sequence of the sgRNA is GAACGCTGGTGGCTTCCTAACGG, wherein A, C, G and T are nucleotide components including modified nucleotide components.

[0021] In some embodiments of the present invention, the modification is, for example, sugar modification, methylation modification, etc.

[0022] The third aspect of the present invention provides a biological material related to the sgRNA of the second aspect of the present invention, wherein the biological material comprises at least one of b1) to b12):

[0023] b1) a nucleic acid molecule encoding the sgRNA of the second aspect of the present invention;

[0024] b2) an expression cassette containing the nucleic acid molecule described in b1);

[0025] b3) a recombinant vector containing the nucleic acid molecule described in b1);

[0026] b4) a recombinant vector containing the expression cassette described in b2);

[0027] b5) a recombinant cell containing the nucleic acid molecule described in b1);

[0028] b6) a recombinant cell containing the expression cassette described in b2);

[0029] b7) a recombinant cell containing the recombinant vector described in b3);

[0030] b8) a recombinant cell containing the recombinant vector described in b4);

[0031] b9) a recombinant microorganism containing the nucleic acid molecule described in b1);

[0032] b10) a recombinant microorganism containing the expression cassette described in b2);

[0033] b11) a recombinant microorganism containing the recombinant vector described in b3);

[0034] b12) A recombinant microorganism containing the recombinant vector described in b4).

[0035] In some embodiments of the present invention, the recombinant vector is a plasmid vector, a phagemid, a viral vector, a cell vector, a phage, a cosmid, a F cosmid, or an artificial chromosome.

[0036] In some embodiments of the present invention, the plasmid vector may be an optional plasmid, the viral vector may be an optional virus, and the cell vector does not include propagation materials.

[0037] In a fourth aspect, the present invention provides the use of the sgRNA of the second aspect of the present invention or the biomaterial of the third aspect of the present invention in any one of c1) to c8):

[0038] c1) Control of lepidopteran insects;

[0039] c2) preparing products for controlling lepidopteran insects;

[0040] c3) inhibiting the hatching of eggs of lepidopteran insects;

[0041] c4) preparing products that inhibit the hatching of eggs of lepidopteran insects;

[0042] c5) Induce embryonic lethality to lepidopteran insects;

[0043] c6) preparing products that induce embryonic lethality in lepidopteran insects;

[0044] c7) reducing the body weight of lepidopteran insects;

[0045] c8) preparing a product for reducing the body weight of lepidopteran insects.

[0046] In some embodiments of the present invention, the lepidopteran insects include one or more of Spodoptera litura, Spodoptera minor, Manduca sexta, Monarch butterfly, Cotton bollworm, Bombyx mori, Plutella xylostella, Spodoptera exigua and Spodoptera frugiperda.

[0047] In some embodiments of the present invention, the products include but are not limited to reagents, kits and drugs.

[0048] The fifth aspect of the present invention provides a product, comprising the sgRNA of the second aspect of the present invention or the biological material of the third aspect of the present invention.

[0049] In some embodiments of the present invention, the product also includes Cas protein and / or biological materials related to Cas protein.

[0050] In some embodiments of the invention, the Cas protein is selected from Cas9, Cas12a, Cas12e, Cas12b, Cas12i, Cas12h, Cas12c, Cas12d, Cas12f, Cas12g, Cas12k, Cas12j, Cas13a, Cas13b, Cas13c, Cas13d and Cas14, including any recombinant variants thereof, and is particularly selected from Cas9, including any recombinant variants thereof.

[0051] In some embodiments of the present invention, the products include but are not limited to reagents, kits, drugs and pesticides.

[0052] In some embodiments of the present invention, the product has at least one of the following functions:

[0053] (1) Control of Lepidoptera insects;

[0054] (2) Prevent the hatching of eggs of lepidopteran insects;

[0055] (3) Induces embryonic lethality in lepidopteran insects;

[0056] (4) reduce the body weight of lepidopteran insects;

[0057] (5) Change the body shape of Lepidoptera insects.

[0058] In some embodiments of the present invention, the product further comprises a pharmaceutically acceptable carrier, including but not limited to: a diluent, a buffer, a suspension, an emulsion, a granule, an encapsulation, an excipient, a filler, an adhesive, a spray, a transdermal absorbent, a wetting agent, a disintegrant, an absorption enhancer, a surfactant, a colorant, a flavoring agent or an adsorption carrier.

[0059] The sixth aspect of the present invention provides a method for controlling pests, comprising applying the product of the fifth aspect of the present invention to the pests or the pest habitat.

[0060] In some embodiments of the present invention, the method comprises treating pests, food for pests, habitats for pests (soil, area, material or environment where pests are growing or can grow, or materials, cultivated plants, plant propagation materials (such as seeds), soil, surface or space to be protected from attack or infestation by pests) with the product. For example, when treating pests with the product, the product can be injected into the body of the pest.

[0061] In some embodiments of the present invention, an effective dose of the product (i.e., containing an effective dose of sgRNA and Cas protein) is applied to the pest or the pest habitat.

[0062] In general, "effective amount" means the amount of active ingredient required to achieve an observable effect on growth, including necrosis, death, retardation, prevention and removal, destruction or reduction of the presence and activity of the target organism. For the sgRNA and Cas proteins used in the present invention, the effective amount can vary. The effective amount of sgRNA and Cas proteins also varies according to the prevailing conditions, such as the desired insecticidal effect and duration, climate, target species, location, mode of application, etc.

[0063] The seventh aspect of the present invention provides a CRISPR / Cas system, comprising the sgRNA of the second aspect of the present invention or the biological material and Cas protein of the third aspect of the present invention.

[0064] In some embodiments of the invention, the Cas protein is selected from Cas9, Cas12a, Cas12e, Cas12b, Cas12i, Cas12h, Cas12c, Cas12d, Cas12f, Cas12g, Cas12k, Cas12j, Cas13a, Cas13b, Cas13c, Cas13d and Cas14, including any recombinant variants thereof, and is particularly selected from Cas9, including any recombinant variants thereof.

[0065] The beneficial effects of the present invention are:

[0066] The present invention discloses for the first time the application of ceramide synthase CerS6 gene as a target in the control of lepidopteran insects, and knocks out ceramide synthase CerS6 of Spodoptera litura by target gene screening combined with CRISPR / Cas9 technology, proving the importance of ceramide synthase CerS6 to the growth, development and fertility of pests.

[0067] Specifically, the present invention successfully obtained a CerS functional loss mutant in Spodoptera litura using CRISPR / Cas9 technology. The CerS6 mutation seriously affects the amount of eggs laid and the hatching rate of the pests, and can be used for pest control. In the preparation of insect control agents, products that act on CerS6 (such as substances that reduce the activity of CerS6, substances that degrade CerS6, substances that reduce the expression level of CerS6, substances that knock out / knock down CerS6) are used to kill a large number of pests in the egg stage, and pests can be controlled persistently. In addition, during the control process, no drug resistance will be generated, no harm will be done to humans and animals, and no pollution will be done to the environment.

[0068] The present invention provides new clues for understanding the biological significance of CerS6 for life phenomena and makes a great contribution to biological pest control. BRIEF DESCRIPTION OF THE DRAWINGS

[0069] Figure 1 To knock out the CerS6 gene of Spodoptera litura based on the designed CRISPR / Cas9 target site and obtain the genotype map; where A is the selection of the target site, B is the screening of the mutant genotype, and C is the mutation type that can lead to premature termination of protein translation.

[0070] Figure 2 This is a visual representation of the blocked embryonic development after the CerS6 gene of Spodoptera litura was knocked out.

[0071] Figure 3 Comparison of the reproductive capacity between the wild type and CerS6 mutant of Spodoptera litura; A is the egg-laying amount, B is the hatching rate, and C is the weight comparison of the sixth-instar larvae; in the figure, ns represents no significant difference, * represents p < 0.05, ** represents p < 0.01, and **** represents p < 0.001.

[0072] Figure 4 This is a protein sequence analysis diagram of CerS6 homologous genes in insects. DETAILED DESCRIPTION

[0073] The present invention is further described in detail below through specific examples.

[0074] It should be understood that these embodiments are only used to illustrate the present invention and are not used to limit the scope of the present invention.

[0075] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.

[0076] The features and performance of the present invention are further described in detail below in conjunction with the embodiments.

[0077] Example 1 CRISPR / Cas9 system knocks out Spodoptera litura ceramide synthase CerS6

[0078] According to the gene sequence of Spodoptera litura CerS6 (SEQ ID NO: 1), a suitable site was selected based on the selection principle of GG (19N) GG; since Spodoptera litura has three homologous genes for CerS, the target was designed on the CerS6 gene-specific sequence. In this embodiment, the target sequence of sgRNA was GAACGCTGGTGGCTTCCTAA (CGG) (SEQ ID NO: 2).

[0079]

[0080] 2. Amplification of transcription template

[0081] (1) Primer design:

[0082] Forward Primer F (CerS6-sgRNA-F):

[0083] 5'-TAATACGACTCACTATAGGGAACGCTGGTGGCTTCCTAAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCC-3' (SEQ ID NO: 3);

[0084] Reverse Primer R (CerS6-sgRNA-R):

[0085] 5'-AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAA-3' (SEQ ID NO: 4).

[0086] (2) Extension of the template CerS sgRNA template short chain

[0087] The reaction system was prepared as shown in Table 1, and the reaction procedure was 95°C, 3 min; 95°C, 30 s, 55°C, 30 s, 72°C, 30 s, 30 cycles; 72°C, 10 min.

[0088] Table 1 Reaction system

[0089]

[0090] (3) Positive plasmid construction

[0091] The target DNA fragment was recovered from the PCR product in step (2) and ligated into the PMD-18T vector. The ligation system is shown in Table 2.

[0092] Table 2 Connection system

[0093]

[0094] After the ligation solution was placed in a 16°C refrigerator for 3 hours, 10 μL of the ligation solution was added to a centrifuge tube containing competent E. coli, gently blown evenly, placed on ice for 30 minutes, then placed in a 42°C water bath for 90 seconds, immediately taken out, placed on ice for 5-10 minutes, 1 mL of non-antibiotic LB medium was added, and the tube was placed in a shaking incubator for 1 hour and centrifuged at 3000 rpm for 5 minutes, leaving 100 μL of the resuspended bacterial solution. The positive colonies were screened with ampicillin-resistant plate culture medium, and monoclonal colony PCR detection and sequencing verification were performed. The colonies with no nucleotide mutations in the sequencing results were the desired positive colonies.

[0095] The primers used in the above colony PCR detection are PMD-18T-F and sgRNA-R. The PCR product size is about 530bp. The specific sequences of the colony PCR detection primers are as follows:

[0096] PMD-18T-F: 5'-CGGTGATGACGGTGAAAACCTC-3' (SEQ ID NO: 5);

[0097] sgRNA-R: 5'-AAAAAAAGCACCGACTCGGTGCC-3' (SEQ ID NO: 6).

[0098] (4) Amplification of transcription template

[0099] The positive colony plasmid with no nucleotide mutation in the sequencing result was used as template, and the transcription template was amplified with primers (according to The reaction system was as shown in Table 3. Reaction program: 95°C, 3 min; 95°C, 30 s, 55°C, 30 s, 72°C, 30 s, 34 cycles; 72°C, 10 min.

[0100] Table 3 Reaction system

[0101]

[0102] The above system was repeated for 6 tubes. After the reaction was completed, the reaction solutions were combined to a total of 300 μL, and an equal volume of phenol chloroform and isoamyl alcohol was added for purification. After purification, the final concentration was set to 1000 ng / μL to serve as a template for sgRNA synthesis.

[0103] 3. sgRNA Synthesis

[0104] Keep the nucleotides on ice and the 10X Reaction Buffer at room temperature. Kit) The sgRNA synthesis operation was performed according to the instructions of the Kit. The reaction system is shown in Table 4, and the reaction procedure was: 37°C water bath overnight (about 16 hours).

[0105] Table 4 Reaction system

[0106]

[0107]

[0108] Make up 10 μL of reaction solution to 300-400 μL with RNA free water, and add an equal volume of phenol chloroform isoamyl alcohol to purify sgRNA. After purification, the final concentration is set to 500-1000 ng / μL. The final injection concentration is determined according to your needs.

[0109] 4. Egg microinjection for CerS6 knockout and positive individual screening

[0110] The day and night of Spodoptera litura were reversed in advance so that it could lay eggs during the day and facilitate injection. The eggs were laid on kraft paper coated with glue. After the eggs were laid, the egg-carrying paper was cut off and rinsed in running water. The fluff covering the surface was first gently washed off with water, and then the fluff remaining on the surface of the eggs was gently swept off with a brush. The eggs were wetted and transferred to a glass slide, broken into individual eggs, and the eggs on the glass slide were kept wet with a brush to stick to the glass slide after drying. During microinjection, the mixed Cas9 protein and sgRNA mixture (sgRNA concentration is about 500ng / μL, Cas9 concentration is about 300ng / μL) was injected into the egg embryos of Spodoptera litura.

[0111] 5. Mutation Detection and Stability Genetic Analysis

[0112] At the position 150 bp upstream and downstream of the gene target site, forward and reverse primers (CerS6-F, CerS6-R, the sequences are shown in Table 5) were designed and synthesized, and PCR amplification reaction was carried out using the mutant genomic DNA as a template, and base sequencing was performed. The sequencing results were analyzed by base sequence alignment using SnapGene software, and different sequence base mutations were confirmed.

[0113] After testing, a mutant genotype with 14 bases missing was found, as follows: Figure 1 , that is, the Spodoptera litura with CerS6 knocked out was successfully obtained.

[0114] Table 5 Primer sequences

[0115]

[0116]

[0117] Example 2 Phenotype of Spodoptera litura CerS6 gene knockout (knockout using CRISPR / Cas9 system)

[0118] (1) Homozygous embryonic lethality

[0119] The development of the egg masses laid by CerS homozygous and wild-type Spodoptera litura was observed. The results showed that the wild-type developed normally within 3 days after laying eggs. The embryos became darker in color in the late embryonic development stage and finally hatched larvae normally. However, most embryos of CerS homozygous showed no signs of development until they atrophied and the number of individuals that hatched was very small ( Figure 2 ).

[0120] (2) Decreased reproductive capacity and restricted growth and development

[0121] Due to homozygous embryonic lethality ( Figure 3 In this example, the egg laying amount and hatching rate of the heterozygous mutant type (i.e., the hybrid of CerS homozygous and wild type) were further observed. The results showed that there was no significant difference in the egg laying amount between the heterozygous and wild type, but the hatching rate was significantly reduced ( Figure 3 A-B, p<0.05, t-test), which indicates that the knockout of CerS6 can effectively inhibit the hatching rate of Spodoptera litura. In addition, we also observed the weight of the 6th instar larvae of heterozygotes and found that both male and female larvae showed a significant decrease in weight relative to the wild type ( Figure 3 (C, p<0.05, t-test). The above results indicate that the knockout of CerS can effectively inhibit the number of offspring of Spodoptera litura and affect its growth and development.

[0122] Example 3 Analysis of protein sequences of ceramide synthase CerS in insects

[0123] The protein sequences of different isoforms of ceramide synthase CerS from six Lepidoptera species were analyzed for evolutionary conservation. Figure 4 These species include the Lepidoptera: Spodoptera litura, Spodoptera frugiperda, Spodoptera littoralis, Spodoptera exigua, Danaus plexippus, and Bombyx mori. The similarity of protein sequences between species was analyzed using the MEGA software, and it was found that the ceramide synthase CerS protein sequence is highly conserved in insects in evolution ( Figure 4 ). These data provide a theoretical basis for supporting ceramide synthase CerS as a target for lepidopteran pest control.

[0124] The embodiments of the present invention are described in detail above in conjunction with the accompanying drawings, but the present invention is not limited to the above embodiments. Various changes can be made within the knowledge of ordinary technicians in the relevant technical field without departing from the purpose of the present invention. In addition, the embodiments of the present invention and the features in the embodiments can be combined with each other without conflict.

Claims

1. Use of CerS6 gene as a target in a1) and / or a2); a1) Control of Lepidoptera insects; a2) Screening and / or preparing products for controlling lepidopteran insects.

2. A sgRNA that targets the CerS6 gene and can knock out / knock down the CerS6 gene together with the Cas protein.

3. The sgRNA according to claim 2, characterized in that The nucleotide sequence of the sgRNA is GAACGCTGGTGGCTTCCTAACGG, wherein A, C, G and T are nucleotide components including modified nucleotide components.

4. A biological material related to the sgRNA according to claim 2 or 3, characterized in that: The biological material comprises at least one of b1) to b12): b1) a nucleic acid molecule encoding the sgRNA according to claim 2 or 3; b2) an expression cassette containing the nucleic acid molecule described in b1); b3) a recombinant vector containing the nucleic acid molecule described in b1); b4) a recombinant vector containing the expression cassette described in b2); b5) a recombinant cell containing the nucleic acid molecule described in b1); b6) a recombinant cell containing the expression cassette described in b2); b7) a recombinant cell containing the recombinant vector described in b3); b8) a recombinant cell containing the recombinant vector described in b4); b9) a recombinant microorganism containing the nucleic acid molecule described in b1); b10) a recombinant microorganism containing the expression cassette described in b2); b11) a recombinant microorganism containing the recombinant vector described in b3); b12) A recombinant microorganism containing the recombinant vector described in b4).

5. Use of the sgRNA according to claim 2 or 3 or the biological material according to claim 4 in any one of c1) to c8): c1) Control of Lepidoptera insects; c2) preparing products for controlling lepidopteran insects; c3) inhibiting the hatching of eggs of lepidopteran insects; c4) preparing products that inhibit the hatching of eggs of lepidopteran insects; c5) Induce embryonic lethality to lepidopteran insects; c6) preparing products that induce embryonic lethality in lepidopteran insects; c7) reducing the body weight of lepidopteran insects; c8) preparing a product for reducing the body weight of lepidopteran insects.

6. The use according to claim 5, characterized in that: The lepidopteran insects include one or more of the group consisting of the following: Spodoptera litura, Spodoptera litura, Manduca sexta, Monarch butterfly, Cotton bollworm, Bombyx moth, Plutella xylostella, Spodoptera exigua and Spodoptera frugiperda.

7. A product comprising the sgRNA of claim 2 or 3 or the biological material of claim 4; Preferably, the product also includes Cas protein and / or biological material associated with Cas protein.

8. A method for controlling pests, comprising applying the product of claim 7 to the pests or the habitat of the pests.

9. The method according to claim 8, characterized in that The pests include insects of the order Lepidoptera.

10. A CRISPR / Cas system, comprising the sgRNA of claim 2 or 3 or the biological material of claim 4 and a Cas protein.

Citation Information

Patent Citations

  • Mammalian cells for producing a secreted protein

    CN109072236A

  • Application of acetyltransferase Tip60 in insect control

    CN116716295A